NIH Notices

  • Inauguration Day (January 20, 2017) Impact on NIH Grant Application Due Dates and Support
    (NOT-OD-17-033) National Institutes of Health
  • Notice Announcing Availability of Common Data Elements for Tobacco Regulatory Research via the PhenX Toolkit
    (NOT-OD-17-034) National Institutes of Health
  • Reminder: New Appendix policy for NIH/AHRQ/NIOSH Applications submitted for Due Dates On or After January 25, 2017
    (NOT-OD-17-035) National Institutes of Health
    Agency for Healthcare Research and Quality
    National Institute for Occupational Safety and Health
  • Notice of a Pre-Application Technical Assistance Webinar for RFA-AT-17-001 and RFA-AT-17-002 “Pain Management Collaboratory – Pragmatic Clinical Trials Demonstration Projects (UG3/UH3)” and “Pain Management Collaboratory – Coordinating Center (U24)”
    (NOT-AT-17-001)
    National Center for Complementary and Integrative Health
  • Notice on NCCIH’s Participation in PA-17-101 “Research on the Health of Women of Underrepresented, Understudied and Underreported (U3) Populations – An ORWH FY17 Administrative Supplement (Admin Supp)”
    (NOT-AT-17-002)
    National Center for Complementary and Integrative Health
  • Notice of Correction to Key Dates in RFA-CA-17-015 “Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies on the Tumor Microenvironment (U01)”
    (NOT-CA-17-013)
    National Cancer Institute
  • Notice of Correction to Key Dates in RFA-CA-17-016 “Resource Center for the Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies (U24)”
    (NOT-CA-17-014)
    National Cancer Institute
  • Notice of Correction to Key Dates in RFA-CA-17-001 “Canine Immunotherapy Trials and Correlative Studies (U01)”
    (NOT-CA-17-015)
    National Cancer Institute
  • Notice of Correction to Key Dates in RFA-CA-17-002 “Coordinating Center for Canine Immunotherapy Trials and Correlative Studies (U24)”
    (NOT-CA-17-016)
    National Cancer Institute
  • Notice of Change of Application Due Date to RFA-CA-16-501 “Limited Competition: Cancer Immunotherapy Trials Network (CITN)(UM1)
    (NOT-CA-17-017)
    National Cancer Institute
  • Notice of NIDDK Participation in PA-17-098 “Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp)”
    (NOT-DK-17-008)
    National Institute of Diabetes and Digestive and Kidney Diseases
  • Request for Information (RFI) for Investigating the Role of Microbiome in Heart, Lung, and Blood Diseases and Sleep Disorders in HIV-infected Individuals
    (NOT-HL-16-482)
    National Heart, Lung, and Blood Institute
  • Notice of NHLBI’s Participation in PA-17-078 “Administrative Supplement for Research on Sex/Gender Influences (Admin Supp)”
    (NOT-HL-17-483)
    National Heart, Lung, and Blood Institute
  • Clarification on the Number of Applications Allowed per Organization for RFA-OH-17-001: Miner Safety and Health Training Program-Western United States (U60)
    (NOT-OH-17-007)
    National Institute for Occupational Safety and Health
Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s